View our webinar for news and views on the latest developments. Our expert panel, chaired by Madeleine Armstrong, News Editor at Evaluate Vantage and author of our latest report on gene editing, featured Sekar Kathiresan, co-founder and CEO of Verve Therapeutics, Amanda Miklus, Managing Consultant and Shardha Millington, Consultant at Citeline.
The panel discussed topics such as:
- The latest gene editing technology and trends in the market
- The regulators’ stance on gene editing
- The latest deal making activity and the reality of investment in gene editing companies
